23andMe | GenomeWeb

23andMe

Page Leaving 23andMe

Andy Page is leaving his position as president of 23andMe, Recode reports.

The project is the consumer genomics firm's latest effort to improve diversity in genetics research. 

The firm said the panel will help include African Americans in health-focused genetic research, which has been skewed towards people with European ancestry. 

Living DNA can break down the origins of a customer’s ancestry into 21 distinct regions within Britain alone, as well as across 80 different worldwide populations.

A new PGen study reports that nearly 6 percent of consumers made changes to their prescription medication based on pharmacogenomic testing. 

A recent study examining the websites of 30 DTC genomics firms found that many do not follow international recommendations for disclosing information to customers.

As many as 10,000 Nevadans will get free genetic testing through a large population health study being conducted by non-profit care network Renown Health. 

Constance Watson at the Spectator writes that consumer personal genomics is "fascinating," but also a little worrying.

The study confirmed 17 previously identified loci, and uncovered 14 new ones that researchers hope can improve understanding of BCC pathogenesis and inform strategies for prevention.

23andMe's database has enabled it to link loci to disease and fuel better understanding of diseases like depression, KQED Science says.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.